Safety and Immunogenicity of a Tetravalent Live-Attenuated Dengue Vaccine in Flavivirus-Naive Infants

A Phase I/II observer-blind, randomized, controlled trial evaluated the safety and immunogenicity of a dengue virus (DENV) vaccine candidate in healthy Thai infants (aged 12–15 months) without measurable pre-vaccination neutralizing antibodies to DENV and Japanese encephalitis virus. Fifty-one subje...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Watanaveeradej, Veerachai, Simasathien, Sriluck, Nisalak, Ananda, Endy, Timothy P., Jarman, Richard G., Innis, Bruce L., Thomas, Stephen J., Gibbons, Robert V., Hengprasert, Sumetha, Samakoses, Rudiwilai, Kerdpanich, Angkool, Vaughn, David W., Putnak, J. Robert, Eckels, Kenneth H., Barrera, Rafael De La, Mammen, Mammen P.
Materialtyp: Artigo
Språk:Inglês
Publicerad: The American Society of Tropical Medicine and Hygiene 2011
Ämnen:
Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3144835/
https://ncbi.nlm.nih.gov/pubmed/21813857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.2011.10-0501
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk